The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change+0.1% to $407.00
Predicted High$407.00at 6 months
Predicted Low$392.00at 2 months
Max Drawdown (predicted)-3.6%
Forecast
The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded.
Predicted Aug 4, 2026 2:48 am
Neutral
HCA trends range-bound to
$407.00
(+0.1% from $406.61)
by Feb 2027.
dip-then-recover
ThesisHCA sits slightly above composite fair value with negative sentiment, policy overhang, and a fading momentum profile after a -17% 6-month run. Expect mild near-term drift lower toward the $388 fair value anchor, then stabilization as the strong earnings beat streak and low beta provide support, roughly matching the flat deterministic baseline over 6 months.
Invalidated ifA break below $345 on policy news or a miss on next earnings would invalidate the stabilization thesis; conversely a decisive close above $425 negates the near-term dip.
Checkpointtime after the call
Datewhen it gets graded
Predictedthe claim: closing price
Current priceactual close — fills in over time
Predicted returnpredicted vs $406.61 at call
Conv.brain's confidence, 1–10
Driverwhy the brain put the point here
Prediction made
Aug 4, 2026
—
$406.61at call
—
—
The anchor — every point below is measured from this price and date.
2 weeks
Aug 18, 2026
$377.08–$436.14typical range · internal point $403.50
—
±7.3%
6/10
Sentiment overhang and value gravity pull mildly lower
What actually happened:
closed $404.98
on Aug 17, 2026 = -0.4% vs the call
(predicted -0.8%)
· direction HIT
(called flat, was flat)
· off by 0.4 pp
· accuracy 10/10
· typical range ±7.3%:
inside the band
· S&P +0.6%
over the same window — beat it
1 month
Sep 4, 2026
$363.81–$449.41typical range · internal point $398.00
—
±10.5%
6/10
Drift toward composite fair value near 388
2 months
Oct 4, 2026
$392.00
—
-3.6%
5/10
Policy overhang lingers, value anchor magnetism
3 months
Nov 4, 2026
$395.00
—
-2.9%
5/10
Q3 print likely another beat stabilizes tape
4 months
Dec 4, 2026
$400.00
—
-1.6%
4/10
Low beta and beat streak bring buyers back
5 months
Jan 4, 2027
$404.00
—
-0.6%
4/10
Mean reversion toward deterministic endpoint
6 months
Feb 4, 2027
$407.00
—
+0.1%
4/10
Converges near flat baseline as narrative resets
Why ranges on the short rungs?
A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here —
three prompt formulations all lost to simply predicting zero — while the stock's own
volatility scale (σ×√t) described those windows well. So the short rungs claim what's
actually knowable: the typical travel, with earnings timing flagged where the variance
will come from. The internal point calls keep being generated and graded to map where
real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.
Deterministic control (v0.3 value line) targets
$407.72
(+0.3%)
— both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it.
Brain: claude-opus-4-7.